—RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT

By afschroeder • July 19, 2025

DeFilipp Z, Choe HK, Efebera YA, Saad A, Farhan S, Lekakis LJ, Yared JA, Schiller GJ, Mapara MY, Assal A, Gooley TA, Bui JD, Lee DD, Lane H, Chen YB. ---RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT. Blood. 2025 Jul 18:blood.2025029584. doi: 10.1182/blood.2025029584. Epub ahead of print. PMID: 40680268.

Tags: Hematology/Oncology, Publications

Related Posts

First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study

Reck M, Patel JD, Gray JE, Reguart N, Cobo M, Pradera JF, Felip E, Cappuzzo F, Garon EB, Neal JW, Mekan S, Safavi F, Fernando[...]

Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH 3rd, Dang VM, Appleton J, O'Connell MP, Cheng P, Valiga AA, Morissette R,[...]

Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns

Zhang TH, Shi Y, Komarova NL, Wodarz D, Kostelny M, Gonzales A, Abbaali I, Chen H, Bresson-Tan G, Dimapasoc M, Harvey W, Oh C, Carmona[...]